Eton Pharmaceuticals (ETON) News Today $13.57 -0.13 (-0.95%) Closing price 04:00 PM EasternExtended Trading$13.68 +0.11 (+0.80%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETON Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Eton Pharmaceuticals IncJune 20 at 10:37 AM | morningstar.comInsiders Back These 3 High Growth CompaniesJune 17 at 4:55 PM | finance.yahoo.comDavid Krempa Sells 6,800 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) StockJune 17 at 4:49 AM | insidertrades.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Growth in Short InterestEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 823,800 shares, an increase of 39.7% from the May 15th total of 589,500 shares. Based on an average trading volume of 307,200 shares, the days-to-cover ratio is presently 2.7 days. Currently, 3.5% of the shares of the stock are short sold.June 16, 2025 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Insider David Krempa Sells 6,800 SharesEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) insider David Krempa sold 6,800 shares of the stock in a transaction on Friday, June 13th. The shares were sold at an average price of $14.77, for a total value of $100,436.00. Following the completion of the transaction, the insider now owns 622,869 shares of the company's stock, valued at $9,199,775.13. The trade was a 1.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.June 16, 2025 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Insider David Krempa Sells 10,223 SharesEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) insider David Krempa sold 10,223 shares of the stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $14.73, for a total transaction of $150,584.79. Following the sale, the insider now directly owns 612,646 shares in the company, valued at approximately $9,024,275.58. The trade was a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.June 16, 2025 | marketbeat.comDavid Krempa Sells 16,977 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) StockEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) insider David Krempa sold 16,977 shares of the firm's stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $14.92, for a total transaction of $253,296.84. Following the sale, the insider now owns 629,669 shares in the company, valued at $9,394,661.48. The trade was a 2.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.June 16, 2025 | marketbeat.comB. Riley Issues Optimistic Forecast for ETON EarningsJune 10, 2025 | americanbankingnews.comB. Riley Forecasts Higher Earnings for Eton PharmaceuticalsEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - B. Riley increased their Q2 2025 EPS estimates for shares of Eton Pharmaceuticals in a note issued to investors on Wednesday, June 4th. B. Riley analyst M. El-Saadi now expects that the company will earn ($0.04) per share for the quarter, uJune 9, 2025 | marketbeat.comEton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More UpsideJune 6, 2025 | seekingalpha.comB. Riley Raises Earnings Estimates for Eton PharmaceuticalsEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Analysts at B. Riley boosted their FY2028 earnings estimates for Eton Pharmaceuticals in a research report issued to clients and investors on Wednesday, June 4th. B. Riley analyst M. El-Saadi now expects that the company will earn $2.35 perJune 6, 2025 | marketbeat.comGLP-1 Nutrition Guidelines; Oral Hydrocortisone OK'd; Vegan Diet for Hot Flashes?June 4, 2025 | msn.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Decrease in Short InterestEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 589,500 shares, a decrease of 16.1% from the April 30th total of 702,500 shares. Based on an average daily trading volume, of 263,300 shares, the days-to-cover ratio is presently 2.2 days. Approximately 2.7% of the company's stock are short sold.June 4, 2025 | marketbeat.comTwo Sigma Advisers LP Invests $662,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Two Sigma Advisers LP purchased a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 49,700 shares of the company's stock, valued at approximaJune 4, 2025 | marketbeat.comTwo Sigma Investments LP Invests $1.50 Million in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Two Sigma Investments LP purchased a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 112,458 shares of the company's stock, valued at approximately $1,498,000. Two Sigma IJune 4, 2025 | marketbeat.comMillennium Management LLC Acquires New Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Millennium Management LLC acquired a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 138,887 shares of the company's stock, valued at approximately $1,850,000. Millennium Management LLC ownedJune 3, 2025 | marketbeat.comHC Wainwright Issues Optimistic Estimate for ETON EarningsEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - HC Wainwright raised their Q3 2025 earnings per share estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Thursday, May 29th. HC Wainwright analyst S. Ramakanth now expects that the company will post earniMay 31, 2025 | marketbeat.comFDA approves Eton’s application for hydrocortisone oral solutionMay 30, 2025 | msn.comEton Pharmaceuticals (NASDAQ:ETON) Shares Gap Up - Here's WhyEton Pharmaceuticals (NASDAQ:ETON) Shares Gap Up - What's Next?May 30, 2025 | marketbeat.comEton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI (hydrocortisone) Oral SolutionMay 30, 2025 | finanznachrichten.deNorthern Trust Corp Purchases 22,827 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Northern Trust Corp boosted its position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 35.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,957 shares of the company's stock afterMay 30, 2025 | marketbeat.comEton Pharmaceuticals stock rises on FDA approval of KHINDIVIMay 29, 2025 | investing.comEton Pharmaceuticals Gains on FDA Green Light for Pediatric Drug KHINDIVIMay 29, 2025 | msn.comEton Pharma wins FDA nod for oral hydrocortisone solutionMay 29, 2025 | msn.comFDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 RevenueMay 29, 2025 | benzinga.comEton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal InsufficiencyMay 29, 2025 | insidermonkey.comEton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral SolutionMay 28, 2025 | globenewswire.comJane Street Group LLC Has $857,000 Stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Jane Street Group LLC grew its holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 328.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,323 shares of the company's stock after buyMay 26, 2025 | marketbeat.comParadigm Capital Management Inc. NY Sells 100,000 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Paradigm Capital Management Inc. NY decreased its holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 33.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 200,000 shares of the company's stock after selMay 22, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Buys New Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)OMERS ADMINISTRATION Corp purchased a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 37,900 shares of the company's stock, valued at approximaMay 21, 2025 | marketbeat.comEton Pharmaceuticals Set To Dominate Orphan Drug NicheMay 21, 2025 | seekingalpha.comQ3 EPS Estimates for Eton Pharmaceuticals Cut by B. RileyEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Equities research analysts at B. Riley lowered their Q3 2025 earnings estimates for Eton Pharmaceuticals in a report issued on Thursday, May 15th. B. Riley analyst M. El-Saadi now expects that the company will post earnings per share of $0.May 20, 2025 | marketbeat.comCubist Systematic Strategies LLC Grows Stock Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Cubist Systematic Strategies LLC lifted its stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 422.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,239 shares of the company's stock afterMay 18, 2025 | marketbeat.comParkman Healthcare Partners LLC Grows Stock Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Parkman Healthcare Partners LLC increased its holdings in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 6.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 276,890 shares of the company's stock afterMay 16, 2025 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2025 Earnings Call TranscriptMay 15, 2025 | msn.comMink Brook Asset Management LLC Takes $6.07 Million Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Mink Brook Asset Management LLC acquired a new stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 455,805 shares of the company's stock, valued at approximately $6,071,000. Eton PharmaMay 15, 2025 | marketbeat.comEton Pharmaceuticals to Participate at Upcoming Investor ConferencesMay 14, 2025 | globenewswire.comA Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 AnalystsMay 14, 2025 | benzinga.comQ1 2025 Eton Pharmaceuticals Inc Earnings CallMay 14, 2025 | finance.yahoo.comEton outlines path to $100M near-term revenue with ET-400 launch and Increlex growthMay 13, 2025 | msn.comEton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comEton Pharmaceuticals Reports First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comZevra Therapeutics's Earnings OutlookMay 12, 2025 | benzinga.comA Look Ahead: Eton Pharmaceuticals's Earnings ForecastMay 12, 2025 | benzinga.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Bought by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC lifted its stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 421.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 89,664 shares of the company's stock after buyinMay 10, 2025 | marketbeat.comEnvestnet Asset Management Inc. Invests $236,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Envestnet Asset Management Inc. acquired a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,740 shares ofMay 10, 2025 | marketbeat.comBarclays PLC Takes Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Barclays PLC acquired a new position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 54,886 shares of the company's stocMay 9, 2025 | marketbeat.com7EYPT : A Peek at EyePoint Pharmaceuticals's Future EarningsMay 6, 2025 | benzinga.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Purchased by Marshall Wace LLPMarshall Wace LLP grew its position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 75.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 36,182 shares of the company's stock after purchasing an additionMay 5, 2025 | marketbeat.com683 Capital Management LLC Purchases New Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)683 Capital Management LLC acquired a new position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 69,000 shares of the company's stMay 4, 2025 | marketbeat.com Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address ETON Media Mentions By Week ETON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼0.460.68▲Average Medical News Sentiment ETON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼104▲ETON Articles Average Week Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SPRY News ETNB News EVO News JANX News OCUL News VERA News ANIP News BGM News TVTX News CVAC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
